Atlas Trials

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Clinical trial NCT03571334 · RECRUITING

Trial details

NCT number
NCT03571334
Sponsor
Medical College of Wisconsin
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral Neuropathy Due to Chemotherapy
Start date
2020-07-08
Primary completion
2023-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.